電能股份(600877.SH):資產重組所涉及標的資產過户完成
格隆匯11月15日丨電能股份(600877.SH)公佈,截至公吿披露日,公司發行股份購買西南設計54.61%股權、芯億達49%股權、瑞晶實業51%股權(“標的資產”),並向中電科技集團重慶聲光電有限公司、中電科投資控股有限公司、中電科核心技術研發投資有限公司非公開發行股票募集配套資金標的資產過户的工商變更登記手續已於近日完成,電能股份已合法持有西南集成電路設計有限責任公司(“西南設計”)100%股權、重慶中科芯億達電子有限公司(“芯億達”)100%股權及深圳市瑞晶實業有限公司(“瑞晶實業”)100%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.